Tempus is a Chicago-based precision medicine company founded in 2015 by Eric Lefkofsky that utilizes artificial intelligence and multimodal data to advance cancer care. The firm specializes in genomic sequencing and clinical-trial matching to facilitate the discovery and delivery of personalized therapeutics.